Immatics N.V. - stock earnings
IMTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -28.0 million USD | 6.3 million USD |
| 2023Q2 | -26.8 million USD | 24.3 million USD |
| 2023Q1 | -16.5 million USD | 10.7 million USD |
| 2022Q4 | -14.2 million USD | 40.4 million USD |
| 2022Q3 | -20.5 million USD | 14.8 million USD |
| 2022Q2 | -21.9 million USD | 15.7 million USD |
| 2022Q1 | 95.6 million USD | 114.8 million USD |
| 2021Q4 | -19.1 million USD | 17.9 million USD |
| 2021Q3 | -31.5 million USD | 7.5 million USD |
| 2021Q2 | -28.2 million USD | 6.2 million USD |
| 2021Q1 | -25.3 million USD | 8.7 million USD |
| 2020Q4 | -27.5 million USD | 11.5 million USD |
| 2020Q3 | -207.8 million USD | 9.2 million USD |
| 2020Q2 | -23.6 million USD | 7.7 million USD |
| 2020Q1 | -9.2 million USD | 7.8 million USD |
| 2019Q4 | -16.5 million USD | 4.9 million USD |
| 2019Q3 | -5.2 million USD | 5.5 million USD |
| 2019Q2 | -7.4 million USD | 6.1 million USD |
| 2019Q1 | -8.7 million USD | 5.2 million USD |
| 2018Q4 | -8.4 million USD | 1.1 million USD |
| 2018Q3 | -8.5 million USD | 1.1 million USD |
| 2018Q2 | -8.5 million USD | 1.1 million USD |
| 2018Q1 | -9.0 million USD | 1.2 million USD |
IMTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.9 million USD | 83.7 million USD |
| 2022 | 40.3 million USD | 185.5 million USD |
| 2021 | -108.1 million USD | 39.5 million USD |
| 2020 | -279.3 million USD | 38.1 million USD |
| 2019 | -35.6 million USD | 20.7 million USD |
| 2018 | -36.0 million USD | 4.3 million USD |
IMTX
Price: $10.77
52 week price:
Earnings Per Share: -1.22 USD
P/E Ratio: -9.17
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 207152
Market Capitalization: 1.2 billion